DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Folger Nolan Fleming Douglas Capital Management Inc.

Folger Nolan Fleming Douglas Capital Management Inc. decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 11.1% during the 2nd quarter, Holdings Channel.com reports. The fund owned 24,576 shares of the medical instruments supplier’s stock after selling 3,065 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $878,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. IFM Investors Pty Ltd raised its stake in DENTSPLY SIRONA by 8.6% during the second quarter. IFM Investors Pty Ltd now owns 37,709 shares of the medical instruments supplier’s stock worth $1,347,000 after acquiring an additional 2,972 shares during the period. Raymond James Trust N.A. increased its stake in shares of DENTSPLY SIRONA by 52.5% in the second quarter. Raymond James Trust N.A. now owns 10,740 shares of the medical instruments supplier’s stock valued at $384,000 after purchasing an additional 3,698 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of DENTSPLY SIRONA by 33.8% in the second quarter. Parkside Financial Bank & Trust now owns 1,224 shares of the medical instruments supplier’s stock valued at $43,000 after purchasing an additional 309 shares during the period. State of Alaska Department of Revenue increased its stake in shares of DENTSPLY SIRONA by 4.5% in the second quarter. State of Alaska Department of Revenue now owns 58,124 shares of the medical instruments supplier’s stock valued at $2,075,000 after purchasing an additional 2,485 shares during the period. Finally, NuWave Investment Management LLC increased its stake in shares of DENTSPLY SIRONA by 22.9% in the second quarter. NuWave Investment Management LLC now owns 8,102 shares of the medical instruments supplier’s stock valued at $289,000 after purchasing an additional 1,510 shares during the period. Institutional investors and hedge funds own 96.00% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded up $0.02 during trading hours on Friday, reaching $29.57. 116,738 shares of the company’s stock were exchanged, compared to its average volume of 2,151,028. The business’s 50-day simple moving average is $34.52 and its two-hundred day simple moving average is $39.22. DENTSPLY SIRONA Inc. has a 12 month low of $29.41 and a 12 month high of $61.18. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $6.37 billion, a P/E ratio of 17.52, a price-to-earnings-growth ratio of 2.50 and a beta of 0.92.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date is Thursday, September 29th. DENTSPLY SIRONA’s dividend payout ratio is 29.59%.

Analyst Ratings Changes

Several equities research analysts have commented on XRAY shares. Piper Sandler dropped their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. The Goldman Sachs Group dropped their price target on shares of DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating on the stock in a research note on Thursday, July 21st. William Blair lowered shares of DENTSPLY SIRONA from a “market perform” rating to an “underperform” rating in a research note on Friday, August 5th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Monday, August 15th. Finally, UBS Group upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and decreased their price objective for the company from $58.00 to $47.00 in a report on Wednesday, June 1st. One analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $48.11.

About DENTSPLY SIRONA

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Further Reading

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.